发明名称 5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS THEREOF AND USES THEREOF
摘要 PROBLEM TO BE SOLVED: To provide laquinimod preparations and methods of producing the same that minimize the amount of DELAQ (des-ethyl-laquinimod; 5-chloro-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide), which is an undesirable synthetic by-product of laquinimod synthesis used in treatment of multiple sclerosis (MS).SOLUTION: A production method comprises: determining by an apparatus the total amount of DELAQ in a sample of a laquinimod batch; and validating the batch for distribution if the sample of the batch is determined to contain DELAQ of less than 0.1 wt.% relative to the combined weight of laquinimod and DELAQ. Also provided is a pharmaceutical composition using the batch.SELECTED DRAWING: None
申请公布号 JP2016053049(A) 申请公布日期 2016.04.14
申请号 JP20150204932 申请日期 2015.10.16
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD 发明人 ULF TOMAS FRISTEDT
分类号 A61K31/4704;C07D215/54 主分类号 A61K31/4704
代理机构 代理人
主权项
地址